- Home
- TRVI vs DSGR Comparison
TRVI vs DSGR Comparison
Compare TRVI & DSGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- DSGR
- Stock Information
- Founded
- TRVI 2011
- DSGR 1952
- Country
- TRVI United States
- DSGR United States
- Employees
- TRVI N/A
- DSGR N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- DSGR Industrial Machinery/Components
- Sector
- TRVI Health Care
- DSGR Industrials
- Exchange
- TRVI Nasdaq
- DSGR Nasdaq
- Market Cap
- TRVI 1.4B
- DSGR 1.3B
- IPO Year
- TRVI 2019
- DSGR N/A
- Fundamental
- Price
- TRVI $13.34
- DSGR $27.95
- Analyst Decision
- TRVI Strong Buy
- DSGR Buy
- Analyst Count
- TRVI 11
- DSGR 1
- Target Price
- TRVI $20.59
- DSGR $41.00
- AVG Volume (30 Days)
- TRVI 1.8M
- DSGR 87.3K
- Earning Date
- TRVI 11-13-2025
- DSGR 10-30-2025
- Dividend Yield
- TRVI N/A
- DSGR N/A
- EPS Growth
- TRVI N/A
- DSGR N/A
- EPS
- TRVI N/A
- DSGR N/A
- Revenue
- TRVI N/A
- DSGR $1,978,887,000.00
- Revenue This Year
- TRVI N/A
- DSGR $11.30
- Revenue Next Year
- TRVI N/A
- DSGR $4.13
- P/E Ratio
- TRVI N/A
- DSGR N/A
- Revenue Growth
- TRVI N/A
- DSGR 14.46
- 52 Week Low
- TRVI $2.36
- DSGR $21.87
- 52 Week High
- TRVI $13.73
- DSGR $40.08
- Technical
- Relative Strength Index (RSI)
- TRVI 72.54
- DSGR 54.81
- Support Level
- TRVI $10.46
- DSGR $25.86
- Resistance Level
- TRVI $12.14
- DSGR $28.59
- Average True Range (ATR)
- TRVI 0.79
- DSGR 1.13
- MACD
- TRVI 0.06
- DSGR 0.25
- Stochastic Oscillator
- TRVI 92.05
- DSGR 83.97
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About DSGR Distribution Solutions Group Inc.
Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education and medical industries.